Asthma doctors say the move will put their patients at risk of life-threatening reactions when they take the drugs at home.
You might consider a new treatment for allergic asthma if your current medication isn’t relieving your symptoms and they are interfering with your daily routine. If you have allergic asthma, a ...
Monoclonal antibodies (mAbs) are medications that target specific proteins to help reduce inflammation in people with severe asthma. The FDA has approved six mAbs for asthma treatment so far.
3don MSN
A new CT-scan-based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to ...
Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...
In this video, Andrea Pappalardo, MD, discusses the developments in targeted therapies and technologies for pediatric asthma.
The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...
2d
News-Medical.Net on MSNNew CT-based score helps predict need for repeat sinus surgeryA new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to ...
Tagtik on MSN12d
Asthma treatment: Finally a major breakthroughThis is the first major breakthrough in 50 years. British researchers have just discovered a new treatment for severe forms ...
The change will make asthma infusion treatments a pharmacy benefit, meaning policyholders will have to self-inject these four asthma infusion medications. Mykal McEldowney/IndyStar USA TODAY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results